Ventas (NYSE:VTR) Given New $99.00 Price Target at Royal Bank Of Canada

Ventas (NYSE:VTR) had its price target raised by investment analysts at Royal Bank Of Canada from $98.00 to $99.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Royal Bank Of Canada’s target price suggests a potential upside of 8.58% from the stock’s current price.

A number of other equities analysts have also commented on VTR. Wells Fargo & Company raised their price target on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Mizuho boosted their price objective on shares of Ventas from $98.00 to $104.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. Evercore restated an “outperform” rating and set a $95.00 target price on shares of Ventas in a research report on Wednesday, April 29th. JPMorgan Chase & Co. raised their target price on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Finally, The Goldman Sachs Group reiterated a “buy” rating and issued a $110.00 price target on shares of Ventas in a research report on Tuesday, May 19th. Fifteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $98.00.

Ventas Stock Performance

VTR stock traded up $0.89 during trading hours on Friday, hitting $91.17. 487,959 shares of the stock were exchanged, compared to its average volume of 3,639,736. Ventas has a 12 month low of $66.38 and a 12 month high of $101.60. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. The firm has a market capitalization of $46.77 billion, a P/E ratio of 168.92, a P/E/G ratio of 2.05 and a beta of 0.69. The company has a 50-day simple moving average of $90.26 and a two-hundred day simple moving average of $86.50.

Insider Activity

In other news, Director Michael J. Embler purchased 2,500 shares of the company’s stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.53% of the company’s stock.

Hedge Funds Weigh In On Ventas

Institutional investors and hedge funds have recently bought and sold shares of the company. Angeles Wealth Management LLC boosted its stake in shares of Ventas by 4.0% during the first quarter. Angeles Wealth Management LLC now owns 3,329 shares of the real estate investment trust’s stock valued at $274,000 after purchasing an additional 128 shares in the last quarter. IHT Wealth Management LLC increased its stake in shares of Ventas by 3.2% in the fourth quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock valued at $343,000 after buying an additional 137 shares during the period. Sequoia Financial Advisors LLC raised its holdings in Ventas by 1.2% in the 1st quarter. Sequoia Financial Advisors LLC now owns 12,894 shares of the real estate investment trust’s stock valued at $1,054,000 after buying an additional 148 shares during the last quarter. Parallel Advisors LLC raised its holdings in Ventas by 4.6% in the 3rd quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock valued at $278,000 after buying an additional 175 shares during the last quarter. Finally, Manchester Capital Management LLC boosted its position in Ventas by 60.5% during the 4th quarter. Manchester Capital Management LLC now owns 491 shares of the real estate investment trust’s stock worth $38,000 after buying an additional 185 shares during the period. Institutional investors and hedge funds own 94.18% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.